Acylhydrazone derivatives and their use in the inhibition, regulation and/or modulation of the signal transduction of kinases

Details for Australian Patent Application No. 2004281906 (hide)

Owner Merck Patent GmbH

Inventors Beier, Norbert; Burgdorf, Lars; Lang, Florian; Gericke, Rolf; Poschke, Oliver; Drosdat, Helga

Agent Davies Collison Cave

Pub. Number AU-A-2004281906

PCT Pub. Number WO2005/037773

Priority 103 46 913.3 09.10.03 DE

Filing date 16 September 2004

Wipo publication date 28 April 2005

International Classifications

C07C 251/86 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/037773 Priority application(s): WO2005/037773

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281916-Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof

2004281885-Method for the production of a hydraulic binding agent, a structural component, use thereof and device therefor